Leading Dermatologist Conducting Clinical Trial With Radiesse For The Treatment Of Facial Descent

Main Category: Cosmetic Medicine / Plastic Surgery
Also Included In: Clinical Trials / Drug Trials
Article Date: 21 Mar 2006 - 0:00 PDT

email to a friend   printer friendly   opinions  

Kenneth Beer, MD announces initiation of a clinical trial to measure the effectiveness of Radiesse for the treatment of facial descent. Facial descent (commonly known as sagging) is one of the cardinal signs of an aging face and it occurs as the skin and subcutaneous structures lose their elasticity. Traditionally, this has been treated with a face lift. However, newer lasers, light sources and injections hold the potential to forestall the need for facial surgery in some patients. Dr. Beer is conducting a clinical trial to determine what role, if any, Radiesse will have in this new approach to the aging face.

Radiesse is presently not FDA approved for cosmetic injections and its use in this area is considered "off label" and therefore investigational.

Radiesse is composed of synthetic calcium hydroxyapatite microspheres suspended in a carrier gel. The chemical composition of calcium hydroxyapatite found in Radiesse is identical to that found in the human body. The longer lasting correction results from the growth of your own tissue's collagen.

To be eligible for this study, patients need to be

1. Between ages 40 and 75 years of age with moderate mid-face descent.
2. If you are female of childbearing potential, you must not be pregnant or nursing and must not plan to become pregnant during the study period.

You are not eligible for this study if you meet any of the following criteria:

1. You have had prior cosmetic procedures within the past year.

2. You have a bleeding or coagulation disorder.

3. You have a chronic infection or inflammation, or severe allergies.

4. You are allergic/sensitive to any component of the test medication.

5. You are currently participating or have participated in another research study.

6. You have a history of poor compliance with medical treatment.

7. Hypersensitivity to any component of the product, active skin inflammation or infection near the treatment area.

If you are interested please notify Monica Yohn, R.N. at 561-655-9055.

Kenneth R. Beer, MD, PA
http://www.palmbeachcosmetic.com

• Additional
• References
• Citations